Results
|
|
421.
|
Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group. [electronic resource] by
- Schiele, F
- Lindgaerde, F
- Eriksson, H
- Bassand, J P
- Wallmark, A
- Hansson, P O
- Grollier, G
- Sjo, M
- Moia, M
- Camez, A
- Smyth, V
- Walker, M
Producer: 19970818
In:
Thrombosis and haemostasis vol. 77
Availability: No items available.
|
|
|
422.
|
|
|
|
423.
|
|
|
|
424.
|
|
|
|
425.
|
|
|
|
426.
|
|
|
|
427.
|
|
|
|
428.
|
|
|
|
429.
|
|
|
|
430.
|
|
|
|
431.
|
|
|
|
432.
|
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. [electronic resource] by
- Eriksson, B I
- Wille-Jørgensen, P
- Kälebo, P
- Mouret, P
- Rosencher, N
- Bösch, P
- Baur, M
- Ekman, S
- Bach, D
- Lindbratt, S
- Close, P
Producer: 19971106
In:
The New England journal of medicine vol. 337
Availability: No items available.
|
|
|
433.
|
|
|
|
434.
|
|
|
|
435.
|
|
|
|
436.
|
|
|
|
437.
|
|
|
|
438.
|
|
|
|
439.
|
|
|
|
440.
|
|